Alex questions the approach of not intervening upon early cancer detection, highlighting the importance of treating cancers found at an early stage. The discussion delves into the ongoing real-world trial in Europe focusing on reducing stage four cancers as a surrogate endpoint to potentially decrease mortality rates.
